reports

Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026

Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…

15 hours ago

MEXC Reports 2.35 Million Users Across AI Trading Suite in First Six Months

VICTORIA, Seychelles, Feb. 10, 2026 /PRNewswire/ -- MEXC, the fastest-growing global cryptocurrency exchange, redefining a user-first approach to digital assets through…

20 hours ago

Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma

February 11, 2026 06:00 ET  | Source: Upstream Bio – Verekitug provided statistically significant and clinically meaningful reductions in annualized…

1 day ago

Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran

BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed…

1 day ago

IRBM Reports Breakthrough in Zika Virus Drug Discovery

ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug discovery research, has announced a major scientific breakthrough…

2 days ago

SEMI Reports 2025 Annual Worldwide Silicon Wafer Shipments and Revenue Results

Shipments Increase in 2025 Amid Strong AI-driven Demand, While Revenue SoftensMILPITAS, Calif., Feb. 10, 2026 /PRNewswire/ -- Worldwide silicon wafer…

2 days ago

MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer’s Disease

TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive…

3 days ago

ASML reports transactions under its current share buyback program

February 09, 2026 08:00 ET  | Source: ASML Netherlands BV ASML reports transactions under its current share buyback program VELDHOVEN,…

3 days ago

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix,…

5 days ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE)…

5 days ago